NCT06350149

Brief Summary

The goal of this study is to determine the extent to which excess dietary simple sugars serve as a secondary mediating factor in Cystic fibrosis-related diabetes (CFRD) development. The main questions it aims to answer are:

  • Whether conducting a randomized 2x2 factorial design that evaluates acute postprandial changes in glucose over 2 hours following ingestion of a mixed meal challenge that varies by glycemic index and consumption of a sugar-sweetened beverage is acceptable and feasible.
  • What are the preliminary changes in postprandial hyperglycemia, islet cell function, and incretin response to a high or low Glycemic Index mixed meal tolerance test (MMTT) with and without Sugar-Sweetened Beverages (SSB) in adolescents and young adults with CF Participants will be randomized to a mixed diet and blood will be drawn before and after the mixed meal challenge.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 22, 2024

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 28, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 5, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

April 5, 2024

Status Verified

April 1, 2024

Enrollment Period

1.4 years

First QC Date

March 28, 2024

Last Update Submit

April 4, 2024

Conditions

Keywords

Cystic FibrosisGlycemic IndexCystic Fibrosis Related Diabetes

Outcome Measures

Primary Outcomes (7)

  • Recruitment Rate

    Recruitment rate of participants. Goal is to recruit 3 participants per month.

    2 years

  • Refusal Rate

    Refusal rates for participation. 20%of screened participants will refuse to participate

    2 years

  • Investigator Fidelity

    Capacity of the research team to manage the intervention. Goal is \>85%.

    2 years

  • Participant Fidelity

    Feasibility of data collection, including primary and secondary outcome measures. Goal is \>85%

    2 years

  • Acceptability

    Acceptability and burden of intervention on participants. Likert scale response of \>3(out of 5) on post study evaluation that study is not burdensome and acceptable

    2 years

  • Retention Rates

    Retention rates as the participants complete the intervention. Goal is \>80%

    2 years

  • Recruitment

    Length of time it takes to recruit enough participants into the study. Goal is to recruit all patients by the end of second quater of the second year.

    2 years

Secondary Outcomes (15)

  • Change in plasma Cysteine (Cys)

    Baseline, 2 hours

  • Change in plasma Cystine (CySS)

    Baseline, 2 hours

  • Change in plasma Glutathione (GSH)

    Baseline, 2 hours

  • Change in plasma Glutathione Disulfide (GSSG)

    Baseline, 2 hours

  • Change in redox potentials (EhCys/ CySS and EhGSH/GSSG)

    Baseline, 2 hours

  • +10 more secondary outcomes

Study Arms (4)

SSB+ HI- GI

EXPERIMENTAL

All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines

Other: Sugar Sweetened Beverages (SSB)Other: Hi GI

SSB + LO- GI

EXPERIMENTAL

All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines

Other: Sugar Sweetened Beverages (SSB)Other: Lo GI

NSSB+ HI- GI

EXPERIMENTAL

All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines

Other: Hi GI

NSSB+ LO- GI

EXPERIMENTAL

All standardized mixed meal challenges will be similar in calories (kcal) and percent of calories from carbohydrates (45%), protein (15%), and fat (40%). Each meal will provide 1/3rd of the subject's estimated kcal needs per current CF nutrition guidelines

Other: Lo GI

Interventions

The following are considered SSBs: non-diet soft drinks/sodas, flavored juice drinks, sweetened tea, energy drinks, and electrolyte replacement drinks.

SSB + LO- GISSB+ HI- GI
Hi GIOTHER

The Glycemic Index of the high-GI meals will be at least 75

Also known as: Hight Glycemic Index Meal
NSSB+ HI- GISSB+ HI- GI
Lo GIOTHER

The Glycemic Index of the low- -GI meals will not be higher than 55.

Also known as: Low Glycemic Index Meal
NSSB+ LO- GISSB + LO- GI

Eligibility Criteria

Age12 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • English speaking
  • Diagnosis of CF based on the presence of two known CF causing mutations and/or positive sweat test
  • Pancreatic insufficiency
  • Baseline dietary consumption of \>10% total kcal from added sugars and self-reported consumption of \>/= sugar-sweetened beverages per week

You may not qualify if:

  • Current use or anticipated use of medication that is known to raise or lower blood glucose in the past 4 weeks.
  • Oral or IV glucocorticoid current or previous use in the past 4 weeks will prohibit enrollment in the study.
  • Recent pulmonary exacerbation within 3 weeks of enrollment and/or an acute illness requiring a change in antibiotics will also exclude participants.
  • BMI below the 5th percentile or greater than the 95th percentile for age and sex
  • FEV1 \<40% or awaiting a lung transplant;
  • Prior lung or liver transplant or kidney or liver dysfunction.
  • Diagnosis of CF liver disease.
  • Uncontrolled exocrine pancreatic insufficiency/malabsorption
  • Diagnosis of CFRD
  • G-tube feeds (bolus and/or continuous)
  • Current enrollment in another intervention study
  • Changes in diet to lose or gain weight
  • Gluten allergy or intolerance
  • Current pregnancy or lactation or plans to become pregnant during study period
  • History of drug or alcohol abuse
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Advanced Pediatrics: Emory Healthcare

Atlanta, Georgia, 30329, United States

RECRUITING

MeSH Terms

Conditions

Cystic Fibrosis

Interventions

Sugar-Sweetened Beverages

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Intervention Hierarchy (Ancestors)

BeveragesDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Tanicia Daley, MD, MPH

    Emory University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tanicia Daley, MD, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 28, 2024

First Posted

April 5, 2024

Study Start

March 22, 2024

Primary Completion

September 1, 2025

Study Completion

September 1, 2025

Last Updated

April 5, 2024

Record last verified: 2024-04

Locations